Nuvation Bio Inc

NYSE:NUVB (USA)   Ordinary Shares - Class A
$ 3.00 -0.18 (-5.66%) 10:08 PM EST
At Loss
P/B:
1.11
Market Cap:
$ 744.51M
Enterprise V:
$ 151.07M
Volume:
1.92M
Avg Vol (2M):
1.79M
Trade In:
Volume:
1.92M
At Loss
Avg Vol (2M):
1.79M

Business Description

Nuvation Bio Inc
NAICS : 541713 SIC : 2834
ISIN : US67080N1019

Share Class Description:

NUVB: Ordinary Shares - Class A
Description
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
Name Current Vs Industry Vs History
Cash-To-Debt 169.02
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 24.65
9-Day RSI 38.53
14-Day RSI 44.45
6-1 Month Momentum % 98.63
12-1 Month Momentum % 51.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 38.58
Quick Ratio 38.58
Cash Ratio 37.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2
Shareholder Yield % 0.06

Financials (Next Earnings Date:2024-08-02 Est.)

NUVB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:NUVB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nuvation Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.32
Beta 0
Volatility % 111.78
14-Day RSI 44.45
14-Day ATR ($) 0.190858
20-Day SMA ($) 3.1465
12-1 Month Momentum % 51.83
52-Week Range ($) 0.95 - 4.1598
Shares Outstanding (Mil) 248.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuvation Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Nuvation Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Nuvation Bio Inc Frequently Asked Questions

What is Nuvation Bio Inc(NUVB)'s stock price today?
The current price of NUVB is $3.00. The 52 week high of NUVB is $4.16 and 52 week low is $0.95.
When is next earnings date of Nuvation Bio Inc(NUVB)?
The next earnings date of Nuvation Bio Inc(NUVB) is 2024-08-02 Est..
Does Nuvation Bio Inc(NUVB) pay dividends? If so, how much?
Nuvation Bio Inc(NUVB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1